Technical Analysis for ANIX - Anixa Biosciences, Inc.

Grade Last Price % Change Price Change
grade F 3.8494 0.52% 0.02
ANIX closed up 0.52 percent on Wednesday, November 13, 2019, on 84 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ANIX trend table...

Date Alert Name Type % Chg
MACD Bearish Centerline Cross Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
Hammer Candlestick Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Fell Below 20 DMA Bearish 0.52%
Fell Below 50 DMA Bearish 0.52%
180 Bearish Setup Bearish Swing Setup 0.52%

Older signals for ANIX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Anixa, a cancer-focused biotechnology company, is harnessing the body's immune system in the fight against cancer. Anixa is developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed. It is developing the CchekTM platform, a series of inexpensive non-invasive blood tests for the early detection of solid tumors, which is based on the body's immune response to the presence of a malignancy. It is also developing chimeric antigen receptor T-cell (CAR-T) based immuno-therapy drugs which genetically engineer a patient's own immune cells to fight cancer. Anixa also continually examines emerging technologies in complementary or related fields for further development and commercialization.
Medicine Biotechnology Cancer Medical Specialties Clinical Medicine Solid Tumors Immune System Cancer Treatments Gene Therapy Leukemia Chimeric Antigen Receptor
Is ANIX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.7
52 Week Low 3.25
Average Volume 39,496
200-Day Moving Average 4.3098
50-Day Moving Average 3.9391
20-Day Moving Average 3.9097
10-Day Moving Average 3.9209
Average True Range 0.1588
ADX 13.22
+DI 16.6247
-DI 24.5187
Chandelier Exit (Long, 3 ATRs ) 3.7636
Chandelier Exit (Short, 3 ATRs ) 4.0264
Upper Bollinger Band 4.0616
Lower Bollinger Band 3.7578
Percent B (%b) 0.3
BandWidth 7.770417
MACD Line -0.0039
MACD Signal Line -0.0009
MACD Histogram -0.0029
Fundamentals Value
Market Cap 58.21 Million
Num Shares 15.1 Million
EPS -0.60
Price-to-Earnings (P/E) Ratio -6.42
Price-to-Sales 51.61
Price-to-Book 5.29
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.12
Resistance 3 (R3) 4.10 3.99 4.07
Resistance 2 (R2) 3.99 3.92 4.00 4.06
Resistance 1 (R1) 3.92 3.88 3.86 3.94 4.04
Pivot Point 3.81 3.81 3.78 3.82 3.81
Support 1 (S1) 3.74 3.74 3.68 3.76 3.65
Support 2 (S2) 3.63 3.70 3.64 3.64
Support 3 (S3) 3.56 3.63 3.62
Support 4 (S4) 3.58